Dietary Supplemental Kava
Study Description
“A Phased Clinical Trial of Dietary Supplemental Kava: Kava Pharmacokinetics”
Kava is a dietary supplement on the US market and is experiencing a resurgence of its use. Its pharmacokinetic information, however, is lacking which is important for its future effective usage as a dietary supplement or potentially as a botanical therapeutics. This phased trial, based on the recommendation from NIH, is to collect pharmacokinetic data of kava in healthy subjects.
Location
Methods
Pharmaceutical medication involved
Patients and healthy individuals accepted
Drug - Kava Dietary Supplement
Participants will be given three 75mg kava capsules.
Additional Information
Official Study Title
A Phased Clinical Trial of Dietary Supplemental Kava: Kava Pharmacokinetics
Clinical Trial ID
NCT03843502
ParticipAid ID
e1w70b
